Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CUSP-06 by OnCusp Therapeutics for Solid Tumor: Likelihood of Approval
CUSP-06 is under clinical development by OnCusp Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
Data Insights
CUSP-06 by OnCusp Therapeutics for Ovarian Cancer: Likelihood of Approval
CUSP-06 is under clinical development by OnCusp Therapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...